| Net earnings | |
| Earnings from discontinued operations, net of tax | |
| Depreciation, depletion and amortization | 394M |
| Deferred income tax expense (benefit) | 86M |
| Unrealized change in fair value of financial instruments | |
| Other noncash charges | |
| Net (increase) decrease in working capital | 136M |
| Decrease in long-term other assets | |
| (Decrease) increase in long-term other liabilities | |
| Cash from operating activities - continuing operations | 726M |
| Cash from operating activities - discontinued operations | |
| Net cash from operating activities | |
| Capital expenditures | -421M |
| Proceeds from property and equipment divestitures | |
| Purchases of short-term investments | |
| Redemptions of short-term investments | |
| Redemptions of long-term investments | |
| Other | 34M |
| Cash from investing activities - continuing operations | 1.29B |
| Cash from investing activities - discontinued operations | |
| Net cash from investing activities | |
| Net commercial paper borrowings (repayments) | |
| Debt repayments | |
| Proceeds from stock option exercises | |
| Repurchases of common stock | |
| Dividends paid on common stock | -32M |
| Excess tax benefits related to share-based compensation | |
| Net cash from financing activities | |
| Effect of exchange rate changes on cash | -9M |
| Net increase in cash and cash equivalents | 662M |
| Cash and cash equivalents at beginning of period (including cash related to assets held for sale) | 1.72B |
| Cash and cash equivalents at end of period (including cash related to assets held for sale) | 2.39B |